SavedAdd your journal

Journals / Üroonkoloji Bülteni / 2020 / Cilt: 19 - Sayı: 3

Management of Patients with Urological Cancers in Turkey during the COVID-19 Pandemic: Recommendations of Uro-oncology Association

Serdar CELİK
İlker TINAY
Fehmi NARTER
Saadettin ESKİÇORAPÇI
Süleyman ATAUS
Levent TÜRKERİ
Sümer BALTACI
Pages
100–103
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we aim to share our recommendations for the daily uro-oncology practice in light of local circumstances in Turkey

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus disease-19 (COVID-19) has been declared as a pandemic by the World Health Organization.
📊
Key Findings & Data:The number of cases has increased over time in correlation with the increasing number of testing worldwide.
💡
Conclusion & Impact:In this report, we aim to share our recommendations for the daily uro-oncology practice in light of local circumstances in Turkey
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Coronavirus disease-19 (COVID-19) has been declared as a pandemic by the World Health Organization. The number of cases has increased over time in correlation with the increasing number of testing worldwide. In order to use the available resources for COVID-19 treatment, urological practice has been limited only to emergency procedures and certain uro-oncological surgeries. In this report, we aim to share our recommendations for the daily uro-oncology practice in light of local circumstances in Turkey

🔖

Cite This Article

CELİK, S., TINAY, İ., NARTER, F., ESKİÇORAPÇI, S., ATAUS, S., TÜRKERİ, L., BALTACI, S. (2020). Management of Patients with Urological Cancers in Turkey during the COVID-19 Pandemic: Recommendations of Uro-oncology Association. Üroonkoloji Bülteni, Cilt: 19 - Sayı: 3, 100–103. https://ajindex.com/articles/334860

References (9)

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020;92:401-402. WHO. Novel Coronavirus 2019. Available at: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 2020;21:629-630. Oddens JR, van der Meijden AP, Sylvester R. One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe? Eur Urol 2004;46:336-338.
  2. Elmamoun MH, Christmas TJ, Woodhouse CR. Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma (TCC)--avoidance, recognition, management and consent. BJU Int 2014;113:34-38.
  3. Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol 2018;73:925-933.
  4. Naselli A, Hurle R, Paparella S, et al. Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Metaanalysis. Eur Urol Focus 2018;4:558-567.
  5. Baltacı S, Bozlu M, Yıldırım A, et al. Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin. BJU Int 2015;116:721-726.
  6. Mmeje CO, Benson CR, Nogueras-González GM, et al. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy. BJU Int 2018;122:89-98.
  7. Boeri L, Soligo M, Frank I, et al. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle invasive Bladder Cancer is Associated with Adverse Survival Outcomes. Eur Urol Oncol 2019;2:390-396.
  8. Gore JL, Lai J, Setodji CM, et al. Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 2009;115:988-996.
  9. Bruins HM, Aben KK, Arends TJ, et al. The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis. Urol Oncol 2016;34:166.e1-6. Ayres BE, Gillatt D, McPhail S, et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 2008;102:1045. Waldert M, Karakiewicz PI, Raman JD, et al. A delay in radical nep